The loss of ATRX increases susceptibility to pancreatic injury and oncogenic KRAS in female but not male mice
<strong>Background</strong> Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in North America, accounting for >30,000 deaths annually. Although somatic activating mutations in KRAS appear in 97% of PDAC patients, additional factors are required to...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2018
|